Magdalena Biosciences
PrivateLast Round
Seed
Jan 10, 2023
Est. Valuation
$5M
Total Funding Raised
$1M
Company Overview
Magdalena Biosciences operates in Healthcare & Life Sciences and is based in Dover, Delaware. Its latest recorded funding round was a Seed round in January 2023.
Magdalena Biosciences is a biotechnology company that develops novel, natural prescription medicines derived from plants for mental health indications such as ADHD and schizophrenia.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Mental Health, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Magdalena Biosciences Comparables
Compare Magdalena Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AJNA BioSciences | 81% | |
| Red Light Holland Corp. | 69% | |
| Schwabe Group | 61% |
For institutional investors. Book with your work email.
Magdalena Biosciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Magdalena Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| One Small Planet | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 15, 2026
Hiring one role, representing 33% of current headcount.
- May 21, 2026
Monthly visitors increased 270% MoM, reaching 726.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 22, 2026
Magdalena Biosciences, Inc. is developing novel prescription medicines on Sep 22nd '26.
For institutional investors. Book with your work email.
Magdalena Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Magdalena Biosciences's valuation, stock price, and market status.
Is Magdalena Biosciences a public or private company?
Magdalena Biosciences is a private company.
What is the current stock price of Magdalena Biosciences?
Magdalena Biosciences is a private company, so its shares have no public market price. Caplight tracks Magdalena Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Magdalena Biosciences worth (valuation)?
Magdalena Biosciences's valuation is estimated at $5.0M based on funding round data.
Can I buy Magdalena Biosciences stock?
Magdalena Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Magdalena Biosciences's last funding round?
Magdalena Biosciences's most recent funding round was Seed on January 10, 2023.
Who are the main investors in Magdalena Biosciences?
Key investors in Magdalena Biosciences include One Small Planet.
Will Magdalena Biosciences IPO soon?
No public IPO plans have been announced for Magdalena Biosciences.
How can I track Magdalena Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Magdalena Biosciences's shares on secondary markets.